Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Tumor Profiling Market Growth From $12.3 Billion In 2026 To $17.95 Billion By 2030 At A CAGR Of 9.9%

Driven by an escalating incidence of cancer, a proliferation of molecular diagnostics facilities, a heightened reliance on targeted cancer treatments, significant advancements in sequencing capabilities, and increased investment in oncology research, the tumor profiling market is poised for substantial expansion. This sector, valued at $11.18 billion in 2025, is projected to reach $12.31 billion by 2026, demonstrating a robust compound annual growth rate of 10.1%.

Foreseeing a period of robust expansion, the tumor profiling market is projected to surge to $17.96 billion by the year 2030, advancing at a compound annual growth rate of 9.9%. This anticipated increase stems from a confluence of factors including the accelerating embrace of precision oncology, a heightened demand for individualized cancer therapies, significant strides in bioinformatics capabilities, the broadening scope of companion diagnostics, and escalating investments directed towards translational cancer research. Key developments shaping the market during this forecast interval are the increasing utilization of next-generation sequencing technologies, a greater reliance on multi-omics profiling strategies, the growing incorporation of artificial intelligence for data analysis, the expanding applications within personalized oncology, and a strengthened emphasis on the identification of novel biomarkers.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24420&type=smp

Tumor Profiling Market Industry Drivers: What Is Driving Revenue Growth?

The increasing appetite for individualized medical care is projected to be a significant catalyst for the expansion of the tumor profiling market. This personalized approach to healthcare focuses on customizing treatments based on a patient’s unique biological makeup, a trend spurred by individuals desiring more accurate therapeutic interventions that promise superior results and minimized adverse effects compared to conventional methods. Tumor profiling plays a crucial role in this paradigm by pinpointing distinct genetic alterations and indicators within a patient’s cancerous tissues, thereby facilitating treatments directed at these specific anomalies and consequently lessening undesirable reactions. An illustrative example can be found in February 2024, when the Personalized Medicine Coalition, a US entity committed to the progress of personalized medicine, reported that personalized medications represented over a third of all newly approved drugs in 2023, continuing a pattern observed for the past four years. Consequently, the escalating need for personalized medicine is directly fueling the growth trajectory of the tumor profiling market.

Tumor Profiling Market Segmentation Trends And Revenue Drivers

The tumor profiling market covered in this report is segmented –

1) By Technique: Genomics, Proteomics, Epigenetics, Metabolomics

2) By Technology: Sequencing Techniques, Quantitative Polymerase Chain Reaction (qPCR), Immunohistochemistry, In Situ Hybridization (ISH), Microarray

3) By Application: Personalized Cancer Medicine, Oncological Diagnostics, Research

Subsegments:

1) By Genomics: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarrays, Sanger sequencing

2) By Proteomics: Mass Spectrometry (MS), Protein Microarrays, Immunohistochemistry (IHC), Western Blotting

3) By Epigenetics: DNA Methylation Analysis, Chromatin Immunoprecipitation Sequencing (ChIP-seq), Histone Modification Profiling, Non-Coding RNA Analysis

4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy, Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), Capillary Electrophoresis-Mass Spectrometry (CE-MS)

#Tumor Profiling Market Growth Trends: What Is Influencing The Future Outlook?

In the competitive landscape of the tumor profiling market, leading enterprises are prioritizing the creation of cutting-edge technologies, including artificial intelligence (AI)-driven diagnostic systems, with the aim of boosting precision and effectiveness in cancer therapies. AI involves the application of sophisticated computing techniques to examine extensive genomic, proteomic, and clinical information, thereby facilitating quicker diagnostic outcomes, tailored therapeutic approaches, and improved oversight of illness advancement. Illustrating this trend, Panakeia Technologies LTD, a UK firm concentrating on AI-powered software for cancer detection and treatment, unveiled PANProfiler Colon in January 2025. This innovative AI software is engineered to assess crucial molecular markers, such as microsatellite instability (MSI) and mismatch repair deficiency (dMMR), directly from H and E stained images of colon cancer tissue specimens. This digital instrumentation permits swift and precise molecular characterization of tumors, a critical step for diagnosing colorectal cancer, identifying Lynch syndrome instances, and guiding individualized treatment choices.

Tumor Profiling Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the tumor profiling market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt. Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., Predictive Oncology Inc.

Access The Complete Tumor Profiling Market Report:

https://www.thebusinessresearchcompany.com/report/tumor-profiling-global-market-report

Tumor Profiling Market Geographic Landscape: Which Region Dominates Industry Growth?

North Americawas the largest region in the tumor profiling market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the tumor profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model